Wound Management & Prevention (WMP) Journal selected Omeza for a “Top Innovation in Wound Care 2022” Award for the Omeza products bundle. The Omeza treatment product line consists of the Omeza® Lidocaine Lavage, Omeza® Collagen Matrix Rx, and Omeza® Skin Protectant, created to decrease inflammation, inhibit biofilm, and increase circulation at any site of care.
Omeza’s proprietary formulations include omega-3, -6, and -9 oils and nutrients in a rapidly penetrating delivery system. The single dose Omeza treatments are anhydrous in nature with a 1-snap application and formulated for head-to-toe use. They were developed to transform the episode of care model for a full spectrum of chronic wounds including venous leg ulcers, diabetic foot ulcers, and pressure ulcers.
Nominated by Prominent Wound Expert
Windy Cole, DPM, CWSP, a member of the WM&P Journal Editorial Review Board, recommended Omeza for inclusion based on recent research presented at grand rounds in the Spring 2022 Symposium on Advanced Wound Care. “In a 12-week pilot study we evaluated the total wound area reduction in subjects treated with the Omeza products and tracked bacterial burden via fluorescence images and PCR cultures throughout. The wounds included in this study were stalled in the inflammatory stage with no signs of healing. The use of Omeza products in combination proved to be effective and safe. The products supported wound healing and reduced bacterial loads in this patient cohort,” stated Dr. Cole.
Wound Management & Prevention Journal is a publication of HMP Global, an omnichannel leader in healthcare content, events, and education, with a mission to improve patient care. WMP focuses on evidence-based management and prevention in all aspects of wound care.